Anil Bachu

Core Faculty

UAMS primary UA Fort Smith

Also affiliated: Boston University (2023); University of Jordan (2022); Texas Tech University (2023); Allegheny Health Network (2019–2024); Springer Nature (Germany) (2023); Indian Institute of Technology Patna (2025); Cornerstone University (2023); University of Connecticut (2023); Essentia Health (2022); University of Hartford (2023); Thomas Jefferson University Hospital (2023); University of Arkansas Medical Center (2023); Oregon State Hospital (2024); Rutland Regional Medical Center (2023); Baptist Health System (2024); Kern Medical Center (2023); Nassau University Medical Center (2023); The University of Texas Rio Grande Valley (2023); Harlem Hospital Center (2023); Griffin Hospital (2022); Arkansas Baptist College (2023–2024); Baptist Health Foundation (2022–2024); Brookwood Baptist Health (2024); Martinsburg VA Medical Center (2022); Universidad Internacional De La Rioja (2023); Ross University School of Medicine (2023); Burrell Behavioral Health (2023); National Pirogov Memorial Medical University, Vinnytsya (2023); University of South Alabama Medical Center (2022); University School (2016); Vitenparken (2023); Memorial Hospital (2022); Arkansas Department of Health (2022); Zucker Hillside Hospital (2023); Quinnipiac University (2023); Wake Forest University (2025); New York University (2022); Case Western Reserve University (2016); B.J. Medical College (2022); Columbia University (2023); Penn State Milton S. Hershey Medical Center (2023)

Faculty Researcher

9 h-index 50 pubs 351 cited

Research Areas

Biomedical Subjects

Links

ORCID

OverviewAI-generated summary

Anil Bachu's research focuses on systematic reviews and meta-analyses of various treatment modalities across a range of health conditions. Recent publications include investigations into the use of electroconvulsive therapy (ECT) for individuals with dementia and behavioral symptoms, and for bipolar versus unipolar depression, examining its association with cognitive impairment and delirium. Bachu has also explored non-opioid psychiatric medications for chronic pain, the treatment of internet addiction in youth, and the intersection of religion and public health during the COVID-19 pandemic. Other work addresses xylazine in the opioid epidemic and corticosteroid-induced psychosis. Bachu has published 49 works, with an h-index of 8 and 301 citations. Key collaborators include researchers from Hendrix College and the University of Arkansas – Fort Smith.

Metrics

h-index: 9
Publications: 50
Citations: 351

Selected Publications

Risk Factor Analysis for Schizophrenia Spectrum Disorder-related Hospitalization in Children, Adolescents, and Transitional-Age-Youth (2026)

The Journal of Nervous and Mental Disease DOI OpenAlex
Systematic Assessment of Stellate Ganglion Block in Post-Traumatic Stress Disorder: Exploring Clinical Utilization and Significance (2025)

European Psychiatry DOI OpenAlex
Demographics, psychiatric comorbidities, and hospital outcomes across eating disorder types in adolescents and youth: insights from US hospitals data (2024)

Frontiers in Child and Adolescent Psychiatry 7 citations DOI OpenAlex
Pediatric anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: Exploring psychosis, related risk factors, and hospital outcomes in a nationwide inpatient sample: A cross-sectional study (2024)

PLoS ONE 5 citations DOI OpenAlex
Perphenazine in Treatment-Resistant Schizophrenia (2024)

Cureus 2 citations DOI OpenAlex
Use of Methylphenidate for Hypoactive Delirium: A Comprehensive Systematic Review (2023)

Psychoactives 3 citations DOI OpenAlex
Exploring the relationship between vitamin D deficiency and comorbid heart disease in Americans with mood disorders: a cross-sectional nationwide study (2023)

Frontiers in Psychiatry 1 citation DOI OpenAlex
Ketamine Augmentation of Electroconvulsive Therapy: A Scoping Review of Dose-Dependent Effects in Major Depressive Disorder (2023)

Cureus 4 citations DOI OpenAlex
Corticosteroid-Induced Psychosis: A Report of Three Cases (2023)

Cureus 10 citations DOI OpenAlex
Electroconvulsive Therapy plus Lithium is Associated with Less Cognitive Impairment and Drug-Induced Delirium in Bipolar Depression Compared to Unipolar Depression (2023)

Annals of Clinical Psychiatry 9 citations DOI OpenAlex
Xylazine in the Opioid Epidemic: A Systematic Review of Case Reports and Clinical Implications (2023)

Cureus 75 citations DOI OpenAlex
Cardiometabolic Comorbidity Risk in Pediatric Patients With Psychiatric Illnesses: A Case-Control Inpatient Study (2022)

Cureus DOI OpenAlex